JAMES TODT: Open Payments
NPI 1922177294 · GLENS FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,864 in 61 payments from 14 companies in 2025. Trend: 2023 $570 · 2024 $722 · 2025 $2,864
Food & beverage: $1,646Travel & lodging: $1,218
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 10 | $1,665 |
| Janssen Biotech, Inc. | 8 | $282 |
| Sumitomo Pharma America, Inc. | 11 | $239 |
| Merck Sharp & Dohme LLC | 9 | $166 |
| Ferring Pharmaceuticals Inc. | 4 | $109 |
| TOLMAR, INC. | 5 | $94 |
| Astellas Pharma US Inc | 3 | $92 |
| Endo USA, Inc. | 4 | $77 |
| PFIZER INC. | 2 | $39 |
| Shionogi Inc | 1 | $25 |
Products named: Axonics, GEMTESA, KEYTRUDA, XTANDI, ERLEADA, RYBREVANT, ADSTILADRIN, JATENZO.
Industry payments across NY — which companies pay providers there.
